Medtronic plc stock (IE00BTN1Y115): shares steady as investors look past recent quarterly update

Medtronic shares traded broadly steady in New York on Tuesday as investors continued to digest the medical technology group’s latest quarterly results and guidance, which were released in late May and confirmed modest growth in its core businesses.

Medtronic shares traded largely unchanged on the New York Stock Exchange on Tuesday, with the stock quoted around USD 83 in afternoon US trading as investors continued to work through the implications of the company’s latest quarterly earnings release and outlook update filed in late May, according to market data from Reuters as of 05/28/2026.

The Ireland-domiciled medical technology group, whose primary listing is on the NYSE under the ticker MDT and which is a constituent of major US healthcare indices, had reported solid but unspectacular growth in its most recent quarter, reaffirming its status as a large-cap defensive name for the United States healthcare market according to its 05/23/2026 earnings press release on its investor relations site.

The stock reaction since the report has been measured, with Medtronic trading in a relatively tight range as the market balances the company’s gradual improvement in growth with ongoing pricing and reimbursement headwinds in key US and European markets, based on trading commentary compiled by Reuters on 05/28/2026.

For German-based investors following the stock on local venues, Medtronic also trades on platforms such as Tradegate in euros, where the shares changed hands at just above EUR 76 on 05/28/2026, tracking the US line while reflecting currency movements between the euro and the US dollar.

As of: 06/02/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Medtronic plc
• Sector/industry: Medical devices and healthcare technology
• Headquarters/country: Dublin, Ireland
• Core markets: United States, Europe, emerging markets
• Key revenue drivers: Cardiovascular devices, neuromodulation systems, diabetes management products, surgical and patient monitoring solutions
• Home exchange/listing venue: New York Stock Exchange (MDT)
• Trading currency: USD

Medtronic plc: core business model

Medtronic focuses on developing and marketing implantable devices and minimally invasive technologies that address chronic diseases, with sales driven largely by hospital procurement cycles and long-term adoption of its cardiology, neuroscience and diabetes product portfolios.

Latest quarterly results for Medtronic plc at a glance

In its most recent earnings release on 05/23/2026, Medtronic reported year-on-year revenue growth in the low- to mid-single-digit percentage range for the quarter ended 04/26/2026, with management highlighting continued momentum in structural heart, cardiac rhythm management and advanced surgical technologies based on the company’s investor presentation published the same day.

According to that 05/23/2026 press release, the company also reiterated its full-year guidance framework for fiscal 2026, pointing to incremental operating margin expansion supported by productivity initiatives and mix improvements, while flagging that pricing pressure in some US procedure categories and ongoing supply-chain normalization would remain key themes through the remainder of the financial year.

Conclusion

Medtronic’s share price performance on Tuesday reflects a balanced investor response to the company’s most recent quarterly update, with the market weighing modest top-line growth and confirmed guidance against sector-specific headwinds in reimbursement and pricing. The latest results underline the group’s role as a diversified medical technology provider with exposure to cardiovascular, neuroscience and diabetes care, and the coming quarters will show how effectively management can translate its innovation pipeline and productivity programs into sustained earnings progress.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.